预防性抗发作药物与早期创伤后发作之间的关联:国际观察多中心研究
Jian Ji1, Juan D Roa G2, Shu-Ling Chong3
1Pediatric Intensive Care Unit Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China.
MedComm
|December 15, 2025
概括
预防性抗发作药物 (ASM) 可以减少创伤性脑损伤 (TBI) 的儿童早期创伤后发作 (EPTS). 这项研究发现ASM使用与较低的EPTS发生率有关,这表明它具有保护作用.
科学领域:
- 神经学 神经学
- 儿科重症监护 儿科重症监护
- 临床药理学 临床药理学
背景情况:
- 早期创伤后 (EPTS) 是儿科创伤性脑损伤 (TBI) 的一个问题.
- 预防性抗发作药物 (ASM) 在TBI后预防EPTS的疗效尚未得到充分证实.
- 了解TBI儿童的EPTS患病率和风险因素对于指导治疗策略至关重要.
研究的目的:
- 为了确定EPTS在儿科TBI患者的患病率.
- 为了比较带有和没有EPTS的儿童之间的临床特征.
- 调查预防性ASM使用与儿科TBI中EPTS发生的相关性.
主要方法:
- 在15个国家的28个儿科重症监护病房进行了观察性研究.
- 从2014年1月到2022年10月,收集了697名TBI儿童的数据.
- 使用后勤回归分析来评估预防性ASM和EPTS之间的关系,控制相关因素.
主要成果:
- 在TBI儿童中,EPTS的总发病率为23.1% (161/697).
- 预防性ASM给了40.2% (280/697) 的患者.
- 使用ASM显着与EPTS的可能性降低相关 (9.6%与32.1%,p <0.001).
- 年龄较小 (≤4岁) 和格拉斯哥昏迷表得分较低 (≤8) 是EPTS的风险因素.
- 芬伊托因, levetiracetam 和 fenobarbital 是最常见的预防性ASM.
结论:
- 预防性ASM使用证明了在儿科TBI中对EPTS的潜在保护作用.
- 这些发现支持在治疗TBI儿童时考虑预防性ASM.
- 进一步的研究可能会完善在这个人群中使用ASM的指南.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
790
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
790
Antiepileptic Drugs: Potassium Channel Activators
603
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
603
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Sodium Channel Blockers
1.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K


